Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $6.32 Million - $11.8 Million
-50,000 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $11.3 Million - $18.4 Million
50,000 New
50,000 $12.7 Million
Q3 2019

Nov 14, 2019

SELL
$12.26 - $18.07 $131,182 - $193,349
-10,700 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$13.7 - $28.34 $146,590 - $303,238
10,700 New
10,700 $157,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $13.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Kingdon Capital Management, L.L.C. Portfolio

Follow Kingdon Capital Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.